日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer

AURKA 抑制有望成为 ARID1A 突变结直肠癌的治疗策略

Rong-Sheng Qin, Chun-Tao Li, Fei Chen, Shu Luo, Chao Wang, Jie Li, Shan Xu, MingWei Kang, Hao-Wen Hu

Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer

评估 ARID1A 作为预测子宫内膜癌患者对免疫检查点抑制剂反应的潜在生物标志物

Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Sultana Razia, Tohru Kiyono, Satoru Kyo

Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression

转录-翻译冲突是细胞转化和癌症进展的障碍

Sujata Jana, Sandipan Brahma, Sonali Arora, Cynthia L Wladyka, Patrick Hoang, Steven Blinka, Rowan Hough, Jessie L Horn, Yuzhen Liu, Li-Jie Wang, Philippe Depeille, Eric Smith, Robert B Montgomery, John K Lee, Michael C Haffner, Funda Vakar-Lopez, Petros Grivas, Jonathan L Wright, Hung-Ming Lam, Pet

Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth

脂质体 DQ 与铜结合可抑制 ARID1A 突变卵巢癌生长

Xuejia Kang, Qi Wang, Siqi Wu, Chuanyu Wang, Manjusha Annaji, Chung-Hui Huang, Jianzhong Shen, Pengyu Chen, R Jayachandra Babu

Polycomb repressive complex 2 binds and stabilizes NANOG to suppress differentiation-related genes to promote self-renewal

多梳抑制复合物2结合并稳定NANOG,从而抑制分化相关基因,促进自我更新。

Da-Wei Yeh ,Cheng Liu ,Juan Carlos Hernandez ,Stanley M Tahara ,Hidekazu Tsukamoto ,Keigo Machida

Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer

鉴定和验证免疫组织化学标记物组以预测肌层浸润性膀胱癌的预后

Yidie Ying #, Ziwei Wang #, Yuxin Tan #, Haotian Cao, Hongliang Gao, Zhensheng Zhang, Shuxiong Zeng, Chuanliang Xu

Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors

低水平 ARID1A 导致适应性免疫抵抗,并使三阴性乳腺癌对免疫检查点抑制剂敏感

Xin-Yu Chen, Bin Li, Ye Wang, Juan Jin, Yu Yang, Lei-Huan Huang, Meng-Di Yang, Jian Zhang, Bi-Yun Wang, Zhi-Ming Shao, Ting Ni, Sheng-Lin Huang, Xi-Chun Hu, Zhong-Hua Tao

Identifying and characterising Thrap3, Bclaf1 and Erh interactions using cross-linking mass spectrometry

使用交联质谱法识别和表征 Thrap3、Bclaf1 和 Erh 相互作用

Liudmila Shcherbakova, Mercedes Pardo, Theodoros Roumeliotis, Jyoti Choudhary

Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy

ARID1A 缺陷结肠癌细胞对放射和 ATR 抑制剂联合治疗的选择性脆弱性

Shan Xu, Ali Sak, Ben Niedermaier, Yasin Bahadir Erol, Michael Groneberg, Emil Mladenov, MingWei Kang, George Iliakis, Martin Stuschke

Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients

日本患者卵巢浆液性粘液性边界肿瘤的突变谱

Hiroki Sasamori, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Ritsuto Fujiwaki, Noriyoshi Ishikawa, Satoru Kyo